Suppr超能文献

COVID-19 大流行对急诊科药物使用筛查和药物过量就诊的影响。

Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations.

机构信息

Georgetown University School of Medicine, Washington, DC, USA.

MedStar Washington Hospital Center, Washington, DC, USA.

出版信息

Am J Emerg Med. 2021 Dec;50:472-476. doi: 10.1016/j.ajem.2021.08.058. Epub 2021 Aug 26.

Abstract

BACKGROUND

The COVID-19 pandemic can exacerbate underlying substance use disorder and has impacted this vulnerable population in a variety of ways. There are limited data regarding how this pandemic has impacted emergency department (ED) patient presentations.

METHODS

We extracted data on ED visits from the electronic health record (EHR) of a large healthcare system in the Washington, DC/Baltimore, MD metropolitan area. The dataset includes data from 7 hospitals on ED visits between 11/1/2019-6/30/2020. The health system utilizes a validated screening program for substance use, Screening, Brief Intervention, and Referral to Treatment (SBIRT), for ED patients who are clinically stable and willing to complete screening. We evaluated trends in patients with a positive SBIRT screen and those presenting with a clinical diagnosis of acute alcohol or substance intoxication/overdose before (11/1/19-2/29/2020-pre) and during the first wave of the COVID pandemic (3/1/2020-6/30/2020-post). Data were described using descriptive statistics. Bivariate analyses were conducted using chi-square test and two-sample t-tests. Interrupted time series analysis was used to evaluate the changes in the weekly trends with the start of the pandemic.

RESULTS

There were 107,930 screens performed in the EDs during the study period (61,961 pre, 45,969 post). The population was primarily African American (64.7%) and female (57.1%). Positive SBIRT screens increased from 12.5% to 15.8% during COVID (p < 0.001). Alcohol intoxication presentations increased as a proportion of positive screens from 12.6% to 14.4% (p = 0.001). A higher percentage of screened patients reported problem drinking (AUDIT score ≥ 7) during the pandemic (2.4% pre vs 3.2% post, p < 0.001). Substance intoxication/overdoses among all screened increased from 2.1% to 3.1% (p < 0.001) and as a percentage of positive screens during the pandemic (16.8% to 20%, p < 0.001). The proportion of opioid vs. non-opioid overdoses remained unchanged before (67%) and during the pandemic (64%, p = 0.33).

DISCUSSION

There was an increase in the proportion of positive SBIRT screens and visits for acute overdoses and intoxication during the first wave of the COVID-19 pandemic. Additional research should focus on mitigation strategies to address substance use during this vulnerable time.

摘要

背景

COVID-19 大流行可能使潜在的物质使用障碍恶化,并以各种方式影响这一脆弱人群。关于大流行如何影响急诊科 (ED) 患者就诊,数据有限。

方法

我们从华盛顿特区/巴尔的摩马里兰州大都市区的一家大型医疗保健系统的电子健康记录 (EHR) 中提取了 ED 就诊数据。该数据集包括 7 家医院在 2019 年 11 月 1 日至 2020 年 6 月 30 日期间的 ED 就诊数据。该医疗系统为愿意接受筛查的临床稳定的 ED 患者使用经验证的物质使用筛查、简短干预和转介治疗 (SBIRT) 计划。我们评估了在 COVID 大流行第一波之前(2019 年 11 月 1 日至 2020 年 2 月 29 日)和期间(2020 年 3 月 1 日至 2020 年 6 月 30 日)阳性 SBIRT 筛查和有临床诊断的急性酒精或物质中毒/过量的患者就诊的趋势。使用描述性统计数据描述数据。使用卡方检验和两样本 t 检验进行了双变量分析。使用中断时间序列分析评估了随着大流行开始,每周趋势的变化。

结果

在研究期间,ED 进行了 107,930 次筛查(61,961 次为前,45,969 次为后)。该人群主要为非裔美国人(64.7%)和女性(57.1%)。阳性 SBIRT 筛查率从 COVID 期间的 12.5%增加到 15.8%(p<0.001)。酒精中毒就诊比例从阳性筛查的 12.6%增加到 14.4%(p=0.001)。在大流行期间,筛查患者报告的问题饮酒(AUDIT 评分≥7)比例更高(2.4%前 vs 3.2%后,p<0.001)。所有筛查的物质中毒/过量患者比例从 2.1%增加到 3.1%(p<0.001),并且在大流行期间阳性筛查的比例(16.8%至 20%,p<0.001)。阿片类药物与非阿片类药物过量的比例在大流行前后保持不变(67%和 64%,p=0.33)。

讨论

在 COVID-19 大流行的第一波期间,SBIRT 阳性筛查和急性中毒和过量就诊的比例有所增加。应进一步研究减轻这一脆弱时期物质使用问题的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e58/8387574/7b12ed31f87b/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验